Product Information
BUMETANIDE 0.5 MG TABLET is a generic product labeled by Advagen Pharma Ltd., priced at $0.1356 per EA under NDC 72888001901. Its NADAC has been published 68 times since Mar 12, 2025.
Strength
.5 mg/1
Manufacturer
Advagen Pharma Ltd.NDC
72888001901
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
BUMETANIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213942On Market Since
1/16/2025
Pharmacological Classes
Price Statistics
The NADAC for BUMETANIDE 0.5 MG TABLET has been published 68 times since Mar 12, 2025, and over the history we have for it it has declined 4.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1356 per EA |
|---|---|
| All-time high | $0.1658 (Jul 16, 2025) |
| All-time low | $0.1265 (Feb 18, 2026) |
| 52-week high | $0.1658 |
| 52-week low | $0.1265 |
| Median price | $0.1416 |
| Average price | $0.1444 |
| Largest weekly change | +13.3% (Mar 19, 2025) |
| Weeks tracked | 68 |
| Tracking since | Mar 12, 2025 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUMETANIDE 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUMETANIDE 0.5 MG TABLET, manufactured by Advagen Pharma Ltd., is $0.1356 per EA (NDC 72888001901), effective Jun 24, 2026.
How has the price of BUMETANIDE 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUMETANIDE 0.5 MG TABLET has declined 4.9%. It has been tracked across 68 weekly CMS publications since Mar 12, 2025.
What are the highest and lowest recorded NADAC prices for BUMETANIDE 0.5 MG TABLET?
Since Mar 12, 2025, the NADAC for BUMETANIDE 0.5 MG TABLET has ranged from a low of $0.1265 (Feb 18, 2026) to a high of $0.1658 (Jul 16, 2025), with a median of $0.1416 per EA.
Are there cheaper alternatives to BUMETANIDE 0.5 MG TABLET?
7 NADAC-published products share the same active ingredient, strength, and dosage form as BUMETANIDE 0.5 MG TABLET, but none are currently priced below it.
Who manufactures BUMETANIDE 0.5 MG TABLET?
BUMETANIDE 0.5 MG TABLET (NDC 72888001901) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.
Related Drugs
Same classification